
The future of shared services is already unfolding—and pharma is leading the way. Across the pharmaceutical sector, Global Shared Services (GSS) is undergoing a quiet revolution. Not driven by headcount or outsourcing—but by artificial intelligence. From cost savings to compliance automation, pharma giants like AstraZeneca and GSK are proving that AI isn’t...